Neopharma Technologies Limited

Neopharma Technologies Ltd has three integrated proprietary technologies for the Drug Testing Industry: myNEO® app, NEOVAULT™ app and NEOVAULT™, for simple, secure, paperless drug testing. Neopharma Technologies IT Platform has 3 parts: 1. myNEO® app that is used by the end user (donor). 2. NEOVAULT™ app that is utilised by the Tester/Supervisor 3. NEOVAULT™ platform which sits in head office run either by the head of HR or the senior company administrator. The apps are available on Apple and Google Play Stores. This proprietary technology is a leader in the digital collection and interpretation of test data via a short 3 second video as opposed to multiple static images. Neopharma's technology has achieved the highest of international cyber security standards over the last 18 months achieving SOC2 Type II, HIPPA, GDPR & ISO 27001 certifications. Benefits for Manufacturers: Creating additional Revenue Stream's. myNEO® – Step by Step Instructions, Instructional Video, AI Test Strip data recording and interpretation, Digital Health Reporting. Providing a marketing advantage and an additional revenue stream for NEOVAULT enabled test kits. NEOVAULT app – simplifies and secures the testing process for TPA's providing time and cost savings. With a good adoption of the NEOVAULT Platform, sales will increase for NEOVAULT enabled test kits. NEOVAULT Platform – new test kits can be incorporated into the NEOVAULT platform to produce the step-by-step instructions and linked to our AI Image Test Strip Recognition for any new test kit. Benefits for Third Party Administrators (TPA's): · Significant Time and Cost Savings · Paperless, AI Image Recognition, More Efficient Workflow. · Provides simple step-by-step instruction at all stages of the testing process. · Provides a chain of custody. · Provides real time reporting to head office. · Minimises the risk of human error. Safe Workplace Best Practice

• Employees 10
• Founded 2017